Ardent Health Announces Closing of Its Initial Public Offering
Ardent Health Partners (NYSE: ARDT) has successfully closed its initial public offering (IPO) of 12,000,000 shares of common stock at $16 per share, raising approximately $192 million in gross proceeds. The company has granted underwriters a 30-day option to purchase an additional 1,800,000 shares. Ardent Health, a leading healthcare provider in growing midsize urban communities across the U.S., began trading on the New York Stock Exchange on July 18, 2024, under the ticker symbol 'ARDT'.
The company plans to use the net proceeds for working capital, acquisitions, debt repayment, and capital expenditures. J.P. Morgan, BofA Securities, and Morgan Stanley acted as lead book-running managers for the offering, with several other firms participating as bookrunners and co-managers.
Ardent Health Partners (NYSE: ARDT) ha concluso con successo il proprio collocamento pubblico iniziale (IPO) di 12.000.000 azioni di azioni ordinarie a 16 dollari per azione, raccogliendo circa 192 milioni di dollari in ricavi lordi. L'azienda ha concesso agli underwriter un'opzione di acquisto di ulteriori 1.800.000 azioni per 30 giorni. Ardent Health, un fornitore leader di servizi sanitari in comunità urbane in crescita negli Stati Uniti, ha iniziato a essere quotata sulla Borsa di New York il 18 luglio 2024, sotto il simbolo 'ARDT'.
L'azienda prevede di utilizzare i proventi netti per capitale circolante, acquisizioni, rimborso del debito e spese in conto capitale. J.P. Morgan, BofA Securities e Morgan Stanley hanno agito come principali gestori dell'offerta, con la partecipazione di diverse altre aziende come bookrunners e co-manager.
Ardent Health Partners (NYSE: ARDT) ha cerrado con éxito su oferta pública inicial (IPO) de 12.000.000 de acciones de acciones ordinarias a 16 dólares por acción, recaudando aproximadamente 192 millones de dólares en ingresos brutos. La empresa ha otorgado a los suscriptores una opción de compra de 1.800.000 acciones adicionales por 30 días. Ardent Health, un proveedor líder de salud en comunidades urbanas en crecimiento en EE. UU., comenzó a cotizar en la Bolsa de Nueva York el 18 de julio de 2024, bajo el símbolo bursátil 'ARDT'.
La compañía planea utilizar los ingresos netos para capital de trabajo, adquisiciones, pago de deudas y gastos de capital. J.P. Morgan, BofA Securities y Morgan Stanley actuaron como principales gerentes de la oferta, con la participación de varias otras empresas como bookrunners y co-gerentes.
아든트 헬스 파트너스(NYSE: ARDT)는 12,000,000주의 보통주를 주당 16달러에 공모하여 약 1억 9200만 달러의 총 수익을 올리며 성공적으로 초기 공모(IPO)를 마감했습니다. 회사는 인수인에게 1,800,000주를 추가로 구매할 수 있는 30일 옵션을 부여했습니다. 아든트 헬스는 미국의 성장하는 중소 도시 커뮤니티에서 활동하는 선도적인 의료 제공업체로, 2024년 7월 18일 뉴욕증권거래소에서 'ARDT'라는 티커 기호로 거래를 시작했습니다.
회사는 순수익을 운전 자본, 인수, 부채 상환 및 자본 지출에 사용할 계획입니다. J.P. 모건, BofA 증권 및 모건 스탠리는 이번 오퍼링의 주관사로 참여했으며, 여러 다른 회사가 북런너와 공동 관리자로 참여했습니다.
Ardent Health Partners (NYSE: ARDT) a réussi à clôturer son introduction en bourse (IPO) avec 12.000.000 actions d'actions ordinaires à 16 dollars par action, levant environ 192 millions de dollars de produits bruts. L'entreprise a accordé aux souscripteurs une option de 30 jours pour acheter 1.800.000 actions supplémentaires. Ardent Health, un fournisseur de soins de santé de premier plan dans des communautés urbaines de taille moyenne en pleine croissance aux États-Unis, a commencé à être cotée à la Bourse de New York le 18 juillet 2024, sous le symbole 'ARDT'.
L'entreprise prévoit d'utiliser les produits nets pour le fonds de roulement, les acquisitions, le remboursement de la dette et les dépenses d'investissement. J.P. Morgan, BofA Securities et Morgan Stanley ont agi en tant que principaux gestionnaires de livres pour l'offre, avec la participation de plusieurs autres entreprises en tant que bookrunners et co-managers.
Ardent Health Partners (NYSE: ARDT) hat erfolgreich sein Initial Public Offering (IPO) von 12.000.000 Aktien zu 16 Dollar pro Aktie abgeschlossen und dabei etwa 192 Millionen Dollar brutto eingenommen. Das Unternehmen hat den Underwritern eine 30-tägige Option eingeräumt, weitere 1.800.000 Aktien zu erwerben. Ardent Health, ein führender Gesundheitsdienstleister in wachsenden mittelgroßen Städten in den USA, begann am 18. Juli 2024 mit dem Handel an der New Yorker Börse unter dem Tickersymbol 'ARDT'.
Das Unternehmen plant, die Nettoerlöse für Betriebs- kapital, Akquisitionen, Schuldenrückzahlung und Investitionsausgaben zu verwenden. J.P. Morgan, BofA Securities und Morgan Stanley fungierten als Hauptbuchführer für das Angebot, während mehrere andere Unternehmen als Buchführer und Co-Manager beteiligt waren.
- Successful IPO raising approximately $192 million in gross proceeds
- Strong underwriter support with major financial institutions as lead book-running managers
- Potential for additional capital through 1,800,000 share option granted to underwriters
- Listing on the prestigious New York Stock Exchange
- Planned use of proceeds for growth initiatives and financial flexibility
- Potential dilution of existing shareholders due to new share issuance
- Increased scrutiny and reporting requirements as a public company
- Market volatility risks associated with newly public stocks
The completion of Ardent Health's initial public offering (IPO) represents a significant milestone for the company. By raising approximately
From a financial perspective, the IPO is advantageous as it provides the company with liquidity and the means to pursue strategic growth opportunities. However, retail investors should also consider the potential risks associated with investing in newly public companies, such as market volatility and the pressure to meet market expectations. The strong involvement of reputable underwriters like J.P. Morgan, BofA Securities and Morgan Stanley as lead book-running managers reinforces the credibility of the offering, which might help stabilize the company's stock price in the short term.
It's important for investors to review the prospectus filed with the SEC to understand the details of the offering and the company's financial health. The prospectus will provide insights into financial metrics, potential risks and the company’s strategic vision. This information will be important for making informed investment decisions.
Ardent Health's IPO timing appears well-calculated given the current favorable market conditions for healthcare companies. The emphasis on working capital, acquisitions and debt repayment reflects a strategic approach to bolstering their market position. The healthcare sector, especially providers in midsize urban communities, is poised for growth due to increasing demand for healthcare services driven by demographic trends like an aging population.
Nevertheless, investors should monitor how effectively Ardent Health deploys the capital raised from the IPO. The company's ability to strategically acquire complementary businesses and integrate them will be pivotal in sustaining its growth trajectory. Additionally, the healthcare sector faces regulatory challenges and changes, which can impact profitability and operational efficiency. Close attention to regulatory developments and the company's adaptability will be essential for investors.
The involvement of multiple reputable institutions in the underwriting process typically indicates thorough due diligence, adding a layer of confidence for potential investors. However, analyzing the broader market trends and the competitive landscape will provide a more comprehensive understanding of Ardent Health's potential market positioning post-IPO.
![Ardent Health President & Chief Executive Officer Marty Bonick and other Ardent Health executives and board members ring the opening bell at the New York Stock Exchange on Thursday, July 18, 2024. Images of NYSE Group, Inc., including the images of the New York Stock Exchange Trading Floor and the Façade of the New York Stock Exchange, the design of each of which is a federally registered service mark of NYSE Group, Inc., are used with permission of NYSE Group, Inc. and its affiliated companies. Neither NYSE Group, Inc. nor its affiliated companies sponsor, approve of or endorse the contents of this website. Neither NYSE Group, Inc. nor its affiliated companies recommend or make any representation as to possible benefits from any securities or investments. Investors should undertake their own due diligence regarding their securities and investment practices. (Photo: NYSE Group, Inc.)](https://mms.businesswire.com/media/20240719421754/en/2191213/4/ARDT-OB-Photo-20240718-Press-12.jpg)
Ardent Health President & Chief Executive Officer Marty Bonick and other Ardent Health executives and board members ring the opening bell at the New York Stock Exchange on Thursday, July 18, 2024. Images of NYSE Group, Inc., including the images of the New York Stock Exchange Trading Floor and the Façade of the New York Stock Exchange, the design of each of which is a federally registered service mark of NYSE Group, Inc., are used with permission of NYSE Group, Inc. and its affiliated companies. Neither NYSE Group, Inc. nor its affiliated companies sponsor, approve of or endorse the contents of this website. Neither NYSE Group, Inc. nor its affiliated companies recommend or make any representation as to possible benefits from any securities or investments. Investors should undertake their own due diligence regarding their securities and investment practices. (Photo: NYSE Group, Inc.)
Ardent Health intends to use the net proceeds from the Offering for working capital, to acquire complementary businesses, products, services or technologies and for general corporate purposes, which may include repayment of debt and capital expenditures. The Company’s common stock began trading on the New York Stock Exchange on July 18, 2024, under the ticker symbol “ARDT.”
J.P. Morgan, BofA Securities and Morgan Stanley acted as lead book-running managers for the Offering. Stephens Inc., Citigroup, Leerink Partners, RBC Capital Markets, Truist Securities, and Mizuho acted as bookrunners. Capital One Securities and Loop Capital Markets acted as co-managers.
A registration statement on Form S-1 (the “Registration Statement”) relating to the securities was declared effective by the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include all statements that are not historical facts. Words such as “anticipates,” “expects,” “intends,” “plans,” “predicts,” “believes,” “seeks,” “estimates,” “could,” “would,” “will,” “may,” “can,” “continue,” “potential,” “should” and the negative of these terms or other comparable terminology often identify forward-looking statements. These forward-looking statements, including statements regarding the use of proceeds, are subject to a number of risks, uncertainties, and assumptions, including those described under "Risk Factors" in Ardent Health’s Registration Statement. Except as required by law, Ardent Health has no obligation to update any of these forward-looking statements to conform these statements to actual results or revised expectations.
About Ardent Health
Ardent Health is a leading provider of healthcare in growing midsize urban communities across the country. With a focus on people and investments in innovative services and technologies, Ardent Health is passionate about making healthcare better and easier to access. Through its subsidiaries, Ardent Health delivers care through a system of 30 acute care hospitals and more than 200 sites of care with over 1,700 providers across six states.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240719421754/en/
Media Relations:
Rebecca Kirkham
Ardent Health
rebecca.kirkham@ardenthealth.com
Alex Jorgensen
Prosek Partners
Ardent@prosek.com
Investor Relations:
Investor.Relations@ardenthealth.com
Source: Ardent Health
FAQ
How much did Ardent Health Partners (ARDT) raise in its IPO?
When did Ardent Health Partners (ARDT) begin trading on the NYSE?
What is the ticker symbol for Ardent Health Partners on the NYSE?
How does Ardent Health Partners (ARDT) plan to use the IPO proceeds?